Description
Identification gene mutations leading to resistance to EGFR therapy
OncQuer TM Scout LB KRAS Mutation Test
Identification gene mutations leading to resistance to EGFR therapy
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
264%
Oncoprint
Hotspot genes: ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, MYD88, NPM1, NRAS, PTPN11, SETBP1, SF3B1, SRSF2, U2AF1, WT1. Full Genes: ASXL1, BCOR, CALR, CEBPA, ETV6, EZH2, IKZF1, NF1, PHF6, PRPF8, RB1, RUNX1, SH2B3, STAG2, TET2, TP53, ZRSR2. Fusion Driver Genes: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6 (TEL), FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A(MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM16, RUNX1 (AML1), TCF3(E2A), TFE3
Oncoprint
Hotspot genes: ABL1, BRAF, CBL, CSF3R, DNMT3A, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, MYD88, NPM1, NRAS, PTPN11, SETBP1, SF3B1, SRSF2, U2AF1, WT1. Full Genes: ASXL1, BCOR, CALR, CEBPA, ETV6, EZH2, IKZF1, NF1, PHF6, PRPF8, RB1, RUNX1, SH2B3, STAG2, TET2, TP53, ZRSR2. Fusion Driver Genes: ABL1, ALK, BCL2, BRAF, CCND1, CREBBP, EGFR, ETV6 (TEL), FGFR1, FGFR2, FUS, HMGA2, JAK2, KMT2A(MLL), MECOM, MET, MLLT10, MLLT3, MYBL1, MYH11, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM16, RUNX1 (AML1), TCF3(E2A), TFE3
-
264%
OncQuer TM Scout LB EGFR Resistance Test
Identification gene mutations leading to resistance to EGFR therapy
OncQuer TM Scout LB EGFR Resistance Test
Identification gene mutations leading to resistance to EGFR therapy
-
255%
GERMLINE BRCA 1 AND 2 – LAL PATH LAB
Panel of BRCA1&2 Genes
-
264%
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.